APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Mesalazine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Mesalazine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025181 pages

Choose your research edition.

Industry ResearchOral Mesalazine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Mesalazine Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Oral Mesalazine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Mesalazine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Mesalazine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Oral Mesalazine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Oral Mesalazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Mesalazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Mesalazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Mesalazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Mesalazine include Teva Pharmaceutical Industries, Ferring Global, AbbVie, Tillotts Pharma, Shire, Salix Pharmaceuticals, Nogra Pharma Limited, Morningside Healthcare and Dr. Falk Pharma UK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Oral Mesalazine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Mesalazine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Mesalazine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oral Mesalazine market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Mesalazine Segment by Company

Teva Pharmaceutical Industries

Ferring Global

AbbVie

Tillotts Pharma

Shire

Salix Pharmaceuticals

Nogra Pharma Limited

Morningside Healthcare

Dr. Falk Pharma UK

Oral Mesalazine Segment by Type

Capsules

Granule

Tablets

Oral Mesalazine Segment by Application

Inflammatory Bowel Disease

Ulcerative Colitis

Crohn's Disease

Others

Oral Mesalazine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Mesalazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Mesalazine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Mesalazine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oral Mesalazine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Mesalazine industry.

Chapter 3: Detailed analysis of Oral Mesalazine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Mesalazinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Mesalazine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Capsules Table 3. Key Players of Granule Table 4. Key Players of Tablets Table 4. Global Oral Mesalazine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Inflammatory Bowel Disease Table 6. Key Players of Ulcerative Colitis Table 7. Key Players of Crohn's Disease Table 8. Key Players of Others Table 9. Global Oral Mesalazine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Oral Mesalazine Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Oral Mesalazine Market Share by Region (2021-2026) Table 12. Global Oral Mesalazine Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Oral Mesalazine Market Share by Region (2027-2032) Table 14. Oral Mesalazine Industry Trends Table 15. Oral Mesalazine Industry Drivers Table 16. Oral Mesalazine Industry Opportunities and Challenges Table 17. Oral Mesalazine Industry Restraints Table 18. Global Oral Mesalazine Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Oral Mesalazine Revenue Market Share by Company (2021-2026) Table 20. Global Oral Mesalazine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Oral Mesalazine Key Company Head Office and Area Served Table 22. Global Oral Mesalazine Company, Product Type & Application Table 23. Global Oral Mesalazine Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Oral Mesalazine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Oral Mesalazine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Oral Mesalazine Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Oral Mesalazine Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Oral Mesalazine Revenue Market Share by Type (2021-2026) Table 30. Global Oral Mesalazine Revenue Market Share by Type (2027-2032) Table 31. Global Oral Mesalazine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Oral Mesalazine Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Oral Mesalazine Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Oral Mesalazine Revenue Market Share by Application (2021-2026) Table 35. Global Oral Mesalazine Revenue Market Share by Application (2027-2032) Table 36. Teva Pharmaceutical Industries Company Information Table 37. Teva Pharmaceutical Industries Business Overview Table 38. Teva Pharmaceutical Industries Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Teva Pharmaceutical Industries Oral Mesalazine Product Portfolio Table 40. Teva Pharmaceutical Industries Recent Development Table 41. Ferring Global Company Information Table 42. Ferring Global Business Overview Table 43. Ferring Global Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Ferring Global Oral Mesalazine Product Portfolio Table 45. Ferring Global Recent Development Table 46. AbbVie Company Information Table 47. AbbVie Business Overview Table 48. AbbVie Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. AbbVie Oral Mesalazine Product Portfolio Table 50. AbbVie Recent Development Table 51. Tillotts Pharma Company Information Table 52. Tillotts Pharma Business Overview Table 53. Tillotts Pharma Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Tillotts Pharma Oral Mesalazine Product Portfolio Table 55. Tillotts Pharma Recent Development Table 56. Shire Company Information Table 57. Shire Business Overview Table 58. Shire Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Shire Oral Mesalazine Product Portfolio Table 60. Shire Recent Development Table 61. Salix Pharmaceuticals Company Information Table 62. Salix Pharmaceuticals Business Overview Table 63. Salix Pharmaceuticals Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Salix Pharmaceuticals Oral Mesalazine Product Portfolio Table 65. Salix Pharmaceuticals Recent Development Table 66. Nogra Pharma Limited Company Information Table 67. Nogra Pharma Limited Business Overview Table 68. Nogra Pharma Limited Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Nogra Pharma Limited Oral Mesalazine Product Portfolio Table 70. Nogra Pharma Limited Recent Development Table 71. Morningside Healthcare Company Information Table 72. Morningside Healthcare Business Overview Table 73. Morningside Healthcare Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Morningside Healthcare Oral Mesalazine Product Portfolio Table 75. Morningside Healthcare Recent Development Table 76. Dr. Falk Pharma UK Company Information Table 77. Dr. Falk Pharma UK Business Overview Table 78. Dr. Falk Pharma UK Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Dr. Falk Pharma UK Oral Mesalazine Product Portfolio Table 80. Dr. Falk Pharma UK Recent Development Table 81. North America Oral Mesalazine Market Size by Type (2021-2026) & (US$ Million) Table 82. North America Oral Mesalazine Market Size by Type (2027-2032) & (US$ Million) Table 83. North America Oral Mesalazine Market Size by Application (2021-2026) & (US$ Million) Table 84. North America Oral Mesalazine Market Size by Application (2027-2032) & (US$ Million) Table 85. North America Oral Mesalazine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Oral Mesalazine Market Size by Country (2021-2026) Table 87. North America Oral Mesalazine Market Size by Country (2027-2032) Table 88. Europe Oral Mesalazine Market Size by Type (2021-2026) & (US$ Million) Table 89. Europe Oral Mesalazine Market Size by Type (2027-2032) & (US$ Million) Table 90. Europe Oral Mesalazine Market Size by Application (2021-2026) & (US$ Million) Table 91. Europe Oral Mesalazine Market Size by Application (2027-2032) & (US$ Million) Table 92. Europe Oral Mesalazine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Oral Mesalazine Market Size by Country (2021-2026) Table 94. Europe Oral Mesalazine Market Size by Country (2027-2032) Table 95. China Oral Mesalazine Market Size by Type (2021-2026) & (US$ Million) Table 96. China Oral Mesalazine Market Size by Type (2027-2032) & (US$ Million) Table 97. China Oral Mesalazine Market Size by Application (2021-2026) & (US$ Million) Table 98. China Oral Mesalazine Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Oral Mesalazine Market Size by Type (2021-2026) & (US$ Million) Table 100. Asia Oral Mesalazine Market Size by Type (2027-2032) & (US$ Million) Table 101. Asia Oral Mesalazine Market Size by Application (2021-2026) & (US$ Million) Table 102. Asia Oral Mesalazine Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Oral Mesalazine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Oral Mesalazine Market Size by Country (2021-2026) Table 105. Asia Oral Mesalazine Market Size by Country (2027-2032) Table 106. South America, Middle East & Africa Oral Mesalazine Market Size by Type (2021-2026) & (US$ Million) Table 107. South America, Middle East & Africa Oral Mesalazine Market Size by Type (2027-2032) & (US$ Million) Table 108. South America, Middle East & Africa Oral Mesalazine Market Size by Application (2021-2026) & (US$ Million) Table 109. South America, Middle East & Africa Oral Mesalazine Market Size by Application (2027-2032) & (US$ Million) Table 110. South America, Middle East & Africa Oral Mesalazine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. South America, Middle East & Africa Oral Mesalazine Market Size by Country (2021-2026) Table 112. South America, Middle East & Africa Oral Mesalazine Market Size by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Oral Mesalazine Product Image Figure 2. Global Oral Mesalazine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Oral Mesalazine Market Share by Type: 2025 VS 2032 Figure 4. Capsules Image Figure 5. Granule Image Figure 6. Tablets Image Figure 7. Global Oral Mesalazine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Oral Mesalazine Market Share by Application: 2025 VS 2032 Figure 9. Inflammatory Bowel Disease Image Figure 10. Ulcerative Colitis Image Figure 11. Crohn's Disease Image Figure 12. Others Image Figure 13. Global Oral Mesalazine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 15. Global Oral Mesalazine Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Oral Mesalazine Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Oral Mesalazine Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Oral Mesalazine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Oral Mesalazine Revenue Market Share by Type (2021-2032) Figure 22. Global Oral Mesalazine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Oral Mesalazine Revenue Market Share by Application (2021-2032) Figure 24. North America Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 25. North America Oral Mesalazine Market Share by Type (2021-2032) Figure 26. North America Oral Mesalazine Market Share by Application (2021-2032) Figure 27. North America Oral Mesalazine Market Share by Country (2021-2032) Figure 28. United States Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 29. Canada Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 31. Europe Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 32. Europe Oral Mesalazine Market Share by Type (2021-2032) Figure 33. Europe Oral Mesalazine Market Share by Application (2021-2032) Figure 34. Europe Oral Mesalazine Market Share by Country (2021-2032) Figure 35. Germany Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 36. France Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 38. Italy Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 39. Russia Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 41. China Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 42. China Oral Mesalazine Market Share by Type (2021-2032) Figure 43. China Oral Mesalazine Market Share by Application (2021-2032) Figure 44. Asia Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 45. Asia Oral Mesalazine Market Share by Type (2021-2032) Figure 46. Asia Oral Mesalazine Market Share by Application (2021-2032) Figure 47. Asia Oral Mesalazine Market Share by Country (2021-2032) Figure 48. Japan Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 52. India Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 53. Australia Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Oral Mesalazine Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Oral Mesalazine Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Oral Mesalazine Market Share by Country (2021-2032) Figure 58. Brazil Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 63. UAE Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 65. Chile Oral Mesalazine Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Granule
  • Tablets
Applications
  • Inflammatory Bowel Disease
  • Ulcerative Colitis
  • Crohn's Disease
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Ferring Global
  • AbbVie
  • Tillotts Pharma
  • Shire
  • Salix Pharmaceuticals
  • Nogra Pharma Limited
  • Morningside Healthcare
  • Dr. Falk Pharma UK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Oral Mesalazine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Capsules
  5. 1.2.3 Granule
  6. 1.2.4 Tablets
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Oral Mesalazine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Inflammatory Bowel Disease
  10. 1.3.3 Ulcerative Colitis
  11. 1.3.4 Crohn's Disease
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Oral Mesalazine Growth Trends by Region
  15. 1.5.1 Global Oral Mesalazine Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Oral Mesalazine Market Size by Region (2021-2026)
  17. 1.5.3 Oral Mesalazine Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Oral Mesalazine Market Dynamics
  1. 2.1 Oral Mesalazine Industry Trends
  2. 2.2 Oral Mesalazine Industry Drivers
  3. 2.3 Oral Mesalazine Industry Opportunities and Challenges
  4. 2.4 Oral Mesalazine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Oral Mesalazine Revenue by Company (2021-2026)
  2. 3.2 Global Oral Mesalazine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Oral Mesalazine Key Company Head office and Area Served
  4. 3.4 Global Oral Mesalazine Company, Product Type & Application
  5. 3.5 Global Oral Mesalazine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Oral Mesalazine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Oral Mesalazine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Oral Mesalazine Tier 1, Tier 2, and Tier 3
4 Oral Mesalazine Market by Type
  1. 4.1 Global Oral Mesalazine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Oral Mesalazine Market Size by Type (2021-2032)
  3. 4.3 Global Oral Mesalazine Market Size Share by Type (2021-2032)
5 Oral Mesalazine Market by Application
  1. 5.1 Global Oral Mesalazine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Oral Mesalazine Market Size by Application (2021-2032)
  3. 5.3 Global Oral Mesalazine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Oral Mesalazine Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Ferring Global
  8. 6.2.1 Ferring Global Company Information
  9. 6.2.2 Ferring Global Business Overview
  10. 6.2.3 Ferring Global Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Ferring Global Oral Mesalazine Product Portfolio
  12. 6.2.5 Ferring Global Recent Developments
  13. 6.3 AbbVie
  14. 6.3.1 AbbVie Company Information
  15. 6.3.2 AbbVie Business Overview
  16. 6.3.3 AbbVie Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 AbbVie Oral Mesalazine Product Portfolio
  18. 6.3.5 AbbVie Recent Developments
  19. 6.4 Tillotts Pharma
  20. 6.4.1 Tillotts Pharma Company Information
  21. 6.4.2 Tillotts Pharma Business Overview
  22. 6.4.3 Tillotts Pharma Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Tillotts Pharma Oral Mesalazine Product Portfolio
  24. 6.4.5 Tillotts Pharma Recent Developments
  25. 6.5 Shire
  26. 6.5.1 Shire Company Information
  27. 6.5.2 Shire Business Overview
  28. 6.5.3 Shire Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Shire Oral Mesalazine Product Portfolio
  30. 6.5.5 Shire Recent Developments
  31. 6.6 Salix Pharmaceuticals
  32. 6.6.1 Salix Pharmaceuticals Company Information
  33. 6.6.2 Salix Pharmaceuticals Business Overview
  34. 6.6.3 Salix Pharmaceuticals Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Salix Pharmaceuticals Oral Mesalazine Product Portfolio
  36. 6.6.5 Salix Pharmaceuticals Recent Developments
  37. 6.7 Nogra Pharma Limited
  38. 6.7.1 Nogra Pharma Limited Company Information
  39. 6.7.2 Nogra Pharma Limited Business Overview
  40. 6.7.3 Nogra Pharma Limited Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Nogra Pharma Limited Oral Mesalazine Product Portfolio
  42. 6.7.5 Nogra Pharma Limited Recent Developments
  43. 6.8 Morningside Healthcare
  44. 6.8.1 Morningside Healthcare Company Information
  45. 6.8.2 Morningside Healthcare Business Overview
  46. 6.8.3 Morningside Healthcare Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Morningside Healthcare Oral Mesalazine Product Portfolio
  48. 6.8.5 Morningside Healthcare Recent Developments
  49. 6.9 Dr. Falk Pharma UK
  50. 6.9.1 Dr. Falk Pharma UK Company Information
  51. 6.9.2 Dr. Falk Pharma UK Business Overview
  52. 6.9.3 Dr. Falk Pharma UK Oral Mesalazine Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Dr. Falk Pharma UK Oral Mesalazine Product Portfolio
  54. 6.9.5 Dr. Falk Pharma UK Recent Developments
7 North America
  1. 7.1 North America Oral Mesalazine Market Size (2021-2032)
  2. 7.2 North America Oral Mesalazine Market Size by Type
  3. 7.2.1 North America Oral Mesalazine Market Size by Type (2021-2026)
  4. 7.2.2 North America Oral Mesalazine Market Size by Type (2027-2032)
  5. 7.2.3 North America Oral Mesalazine Market Share by Type (2021-2032)
  6. 7.3 North America Oral Mesalazine Market Size by Application
  7. 7.3.1 North America Oral Mesalazine Market Size by Application (2021-2026)
  8. 7.3.2 North America Oral Mesalazine Market Size by Application (2027-2032)
  9. 7.3.3 North America Oral Mesalazine Market Share by Application (2021-2032)
  10. 7.4 North America Oral Mesalazine Market Size by Country
  11. 7.4.1 North America Oral Mesalazine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Oral Mesalazine Market Size by Country (2021-2026)
  13. 7.4.3 North America Oral Mesalazine Market Size by Country (2027-2032)
  14. 7.4.4 North America Oral Mesalazine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Oral Mesalazine Market Size (2021-2032)
  2. 8.2 Europe Oral Mesalazine Market Size by Type
  3. 8.2.1 Europe Oral Mesalazine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Oral Mesalazine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Oral Mesalazine Market Share by Type (2021-2032)
  6. 8.3 Europe Oral Mesalazine Market Size by Application
  7. 8.3.1 Europe Oral Mesalazine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Oral Mesalazine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Oral Mesalazine Market Share by Application (2021-2032)
  10. 8.4 Europe Oral Mesalazine Market Size by Country
  11. 8.4.1 Europe Oral Mesalazine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Oral Mesalazine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Oral Mesalazine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Oral Mesalazine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Oral Mesalazine Market Size (2021-2032)
  2. 9.2 China Oral Mesalazine Market Size by Type
  3. 9.2.1 China Oral Mesalazine Market Size by Type (2021-2026)
  4. 9.2.2 China Oral Mesalazine Market Size by Type (2027-2032)
  5. 9.2.3 China Oral Mesalazine Market Share by Type (2021-2032)
  6. 9.3 China Oral Mesalazine Market Size by Application
  7. 9.3.1 China Oral Mesalazine Market Size by Application (2021-2026)
  8. 9.3.2 China Oral Mesalazine Market Size by Application (2027-2032)
  9. 9.3.3 China Oral Mesalazine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Oral Mesalazine Market Size (2021-2032)
  2. 10.2 Asia Oral Mesalazine Market Size by Type
  3. 10.2.1 Asia Oral Mesalazine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Oral Mesalazine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Oral Mesalazine Market Share by Type (2021-2032)
  6. 10.3 Asia Oral Mesalazine Market Size by Application
  7. 10.3.1 Asia Oral Mesalazine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Oral Mesalazine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Oral Mesalazine Market Share by Application (2021-2032)
  10. 10.4 Asia Oral Mesalazine Market Size by Country
  11. 10.4.1 Asia Oral Mesalazine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Oral Mesalazine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Oral Mesalazine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Oral Mesalazine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Oral Mesalazine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Oral Mesalazine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Oral Mesalazine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Oral Mesalazine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Oral Mesalazine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Oral Mesalazine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Oral Mesalazine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Oral Mesalazine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Oral Mesalazine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Oral Mesalazine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Oral Mesalazine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Oral Mesalazine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Oral Mesalazine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Oral Mesalazine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst